P1150 BASELINE CHARACTERISTICS AND TREATMENT EFFICACY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2a AND RIBAVIRIN IN 253 HCV GENOTYPE 1 NONRESPONDER PATIENTS IN A REAL-WORLD SETTING

Autor: Hofmann, W.P., Mauss, S., Baumgarten, A., Boeker, K.H.W., Link, R., Naumann, U., Geyer, P.R., Schuchmann, M., Stoehr, A., Loehr, H., Schober, A., Moog, G., Holm, S., Heyne, R., Eisenbach, C., Lutz, T., Alshuth, U., Hueppe, D.
Zdroj: In Journal of Hepatology April 2014 60(1) Supplement:S466-S466
Databáze: ScienceDirect
Externí odkaz: